Skip to content

ANI Pharmaceuticals

US · ANIP #2919 by market cap Listed 1970
68.55 -0.58 -0.84%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
A
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 7 analysts

Buy
Avg price target 105.14 +53.4%
Price target rangecurrent 68.55
Low85.00
Avg105.14
High121.00
Buy 71% Hold 29% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-06 CCORF -- Hold 90.00
2026-11-06 H.C. Wainwright -- Buy 121.00
2026-11-05 Guggenheim -- Buy 121.00
2026-10-22 J.P. Morgan -- Buy 115.00
2026-10-05 Guggenheim -- Buy 119.00
2026-09-23 Oppenheimer -- Hold 85.00
2026-09-21 H.C. Wainwright -- Buy 121.00
2026-09-09 Leerink Partners -- Buy 104.00
2026-08-25 Barclays -- Buy 100.00
2026-08-11 H.C. Wainwright -- Buy 121.00
2026-08-10 CCORF -- Hold 90.00
2026-08-10 J.P. Morgan -- Buy 115.00
2026-08-07 Guggenheim -- Buy 119.00
2026-08-05 Barclays -- Buy 100.00
2026-07-17 CCORF -- Hold 91.00
2026-07-16 CCORF -- Hold 91.00
2026-07-14 Guggenheim -- Buy 124.00
2026-07-13 H.C. Wainwright -- Buy 121.00
2026-07-09 Guggenheim -- Buy 124.00
2026-05-20 Barclays -- Buy 100.00
2026-05-11 Truist Financial -- Hold --
2026-05-10 Guggenheim -- Buy 124.00
2026-05-08 H.C. Wainwright -- Buy 121.00
2026-04-23 Piper Sandler -- Buy 111.00
2026-04-16 Guggenheim -- Buy 124.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- ±8.76% -2.83% (in line)
2026/Q2 2026-08-07 -- ±9.98% -5.30% (in line)
2026/Q1 2026-05-08 -- ±8.03% -2.44% (in line)
2025/Q4 2026-02-27 -- ±12.21% -4.21% (in line)
2025/Q3 2025-11-07 -- ±8.17% +0.22% (in line)
2025/Q2 2025-08-08 -- ±12.06% +18.07% (beat)
2025/Q1 2025-05-09 -- ±12.57% -7.31% (in line)
2024/Q4 2025-02-28 -- ±15.48% +13.39% (in line)
2024/Q3 2024-11-08 -- ±10.99% +5.24% (in line)
2024/Q2 2024-08-06 -- ±11.66% +6.98% (in line)
2024/Q1 2024-05-10 -- ±7.89% +3.29% (in line)
2023/Q4 2024-02-29 -- ±10.51% +12.26% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:05 · For reference only, not investment advice and not tailored to your situation.

ANI Pharmaceuticals discussion 0 comments

Add a comment